GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Geratherm Medical AG (XTER:GME) » Definitions » 3-Year FCF Growth Rate

Geratherm Medical AG (XTER:GME) 3-Year FCF Growth Rate : 0.00% (As of Jun. 2023)


View and export this data going back to 2000. Start your Free Trial

What is Geratherm Medical AG 3-Year FCF Growth Rate?

Geratherm Medical AG's Free Cash Flow per Share for the three months ended in Jun. 2023 was €0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.

During the past 13 years, the highest 3-Year average Free Cash Flow per Share Growth Rate of Geratherm Medical AG was 317.00% per year. The lowest was -76.30% per year. And the median was 11.50% per year.


Competitive Comparison of Geratherm Medical AG's 3-Year FCF Growth Rate

For the Medical Devices subindustry, Geratherm Medical AG's 3-Year FCF Growth Rate, along with its competitors' market caps and 3-Year FCF Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Geratherm Medical AG's 3-Year FCF Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Geratherm Medical AG's 3-Year FCF Growth Rate distribution charts can be found below:

* The bar in red indicates where Geratherm Medical AG's 3-Year FCF Growth Rate falls into.



Geratherm Medical AG 3-Year FCF Growth Rate Calculation

This is the 3-year average growth rate of Free Cash Flow per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Free Cash Flow per Share growth rate.


Geratherm Medical AG  (XTER:GME) 3-Year FCF Growth Rate Explanation

Free Cash Flow per Share is the amount of Free Cash Flow per outstanding share of the company's stock. Free Cash Flow is considered one of the most important parameters to measure a company's earnings power by value investors because it is not subject to estimates of Depreciation, Depletion and Amortization (DDA). However, when we look at the Free Cash Flow, we should look from a long term perspective, because any year's Free Cash Flow can be drastically affected by the spending on Property, Plant, & Equipment (PPE) of the business in that year. Over the long term, Free Cash Flow should give pretty good picture on the real earnings power of the company. It's used in the calculation of Forward Rate of Return (Yacktman) %.


Geratherm Medical AG 3-Year FCF Growth Rate Related Terms

Thank you for viewing the detailed overview of Geratherm Medical AG's 3-Year FCF Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Geratherm Medical AG (XTER:GME) Business Description

Traded in Other Exchanges
Address
Fahrenheitstrasse 1, Geratal, DEU, 99331
Geratherm Medical AG is a Germany-based medical technology company. The firm operates through four segments: Healthcare Diagnostic, Medical Warming Systems, Cardio/Stroke and Respiratory. Healthcare Diagnostic segment which generates majority revenue provides analog and digital products for measuring body temperature, blood pressure monitors and other products for measuring temperature, as well as related accessories. Medical Warming Systems offers solutions for temperature management at all stages in the pre-clinical and clinical care of the patients, such as rescue situations and operations. Cardio/Stroke segment comprises products for preventing strokes. The Respiratory segment focuses on the development and production of products for pulmonary functional diagnostics.
Executives
Dr. Gert Frank Supervisory Board
Christian Frick Board of Directors

Geratherm Medical AG (XTER:GME) Headlines

From GuruFocus

GameStop's Bear Case Continues to Widen

By Muslim Farooque 07-25-2022

GameStop's NFT Marketplace Launches with ImmutableX

By Business Wire Business Wire 10-31-2022

GameStop Announces CFO Change

By Business Wire Business Wire 07-08-2022

GameStop Corp (GME) Reports Narrowed Net Loss in Q3 2023

By GuruFocus Research 12-06-2023

GameStop Launches NFT Marketplace

By Business Wire Business Wire 07-11-2022

GameStop Discloses Second Quarter 2023 Results

By Marketwired 09-06-2023

2 Stocks Primed for a Short Squeeze

By Ben Alaimo 05-17-2022

GameStop Announces Release Date for Third Quarter Fiscal 2022 Results

By Business Wire Business Wire 11-28-2022